Healthcare startups are driving a takeover boom

Healthcare startups are driving a takeover boom

Hi, 

Morning, and welcome to Insider Healthcare. I’m Allison DeAngelis, and today in healthcare news:

If you’re new to this newsletter, sign up here. If you’ve got biotech/pharmaceutical industry tips, email me at adeangelis@insider.com or tweet @ADeAngelis_bio. Now, let’s dive into the news….


Ro cofounder Zachariah Reitano with Modern Fertility cofounders Afton Vechery (left) and Carly Leahy.

Ro cofounder Zachariah Reitano with Modern Fertility cofounders Afton Vechery (left) and Carly Leahy.

Ro


Healthcare startups are driving a takeover boom. A top digital health analyst explains what’s driving it.

  • Many digital health companies started by solving singular pain points within healthcare, Megan Hernbroth reports. 
  • Now that the market has matured, users are looking for companies that offer more comprehensive software.
  • Just as consolidation led to “mega-biotechs,” a few companies stand to win big in digital health.

Get more insight here >>


Pear Therapeutics  reSET-O digital therapeutics app

A patient uses Pear’s reSET-O app to treat opioid use disorder.

Pear Therapeutics


Pear Therapeutics is going public in a $1.6 billion SPAC deal. Its projected revenue reveals just how hard it is to make money with a doctor-prescribed app.

Read more here >>


Dr. Ash K. Tewari, M.Ch, System Chairman and Professor, Icahn School of Medicine at Mount Sinai; Milton and Carroll Petrie Department of Urology, Mount Sinai Health System and Dr. Madhav Dhodapkar, Arthur and Isabel Bunker Professor, Chief of Section of Hematology and Co-Leader, Cancer Immunology Program, Yale University in a discussion with Dr. Soumya Swaminathan, Deputy Director General, WHO during the Hindustan Times Leadership Summit at Hyatt Regency on November 30, 2017 in New Delhi, India.

Dr. Ash K. Tewari, M.Ch, System Chairman and Professor, Icahn School of Medicine at Mount Sinai; Milton and Carroll Petrie Department of Urology, Mount Sinai Health System and Dr. Madhav Dhodapkar, Arthur and Isabel Bunker Professor, Chief of Section of Hematology and Co-Leader, Cancer Immunology Program, Yale University in a discussion with Dr. Soumya Swaminathan, Deputy Director General, WHO during the Hindustan Times Leadership Summit at Hyatt Regency on November 30, 2017 in New Delhi, India.

Sanchit Khanna/Hindustan Times/Getty Images


Drugmakers are pushing forward with COVID-19 booster shots, but the WHO’s top scientist doesn’t know if it’s a good idea

Hear more from Swaminathan here >>


More stories we’re reading today:


– Allison

https://ragheadnews.com

Leave a Reply

Your email address will not be published. Required fields are marked *